A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden.
Rebeck ON, Wallace MJ, Prusa J, Ning J, Evbuomwan EM, Rengarajan S, Habimana-Griffin L, Kwak S, Zahrah D, Tung J, Liao J, Mahmud B, Fishbein SRS, Ramirez Tovar ES, Mehta R, Wang B, Gorelik MG, Helmink BA, Dantas G.
Rebeck ON, et al. Among authors: wallace mj.
Cell Chem Biol. 2025 Jan 16;32(1):98-110.e7. doi: 10.1016/j.chembiol.2024.10.013. Epub 2024 Nov 20.
Cell Chem Biol. 2025.
PMID: 39571582
Free article.